Endo International plc (NASDAQ: ENDP) stock fell -13.71% on Friday to $0.45 against a previous-day closing price of $0.52. With 28.66 million shares changed hands, the volume of the stock remained lighter than its average volume of 44.36 million shares. During the session, the Drug Manufacturers – Specialty & Generic company that operates in wider Healthcare sector, reached to the highest price of $0.5500 whereas the lowest price it dropped to was $0.4300. The 52-week range on ENDP shows that it touched its highest point at $7.07 and its lowest point at $0.28 during that stretch. It currently has a 1-year price target of $1.33. Beta for the stock currently stands at 1.08.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ENDP was up-trending over the past week, with a rise of 8.78%, but this was up by 17.67% over a month. Three-month performance dropped to -78.12% while six-month performance fell -85.82%. The stock lost -90.76% in the past year, while it has lost -88.01% so far this year. A look at the trailing 12-month EPS for ENDP yields -2.92 with Next year EPS estimates of 0.57. For the next quarter, that number is -0.14. This implies an EPS growth rate of -584.60% for this year and -37.53% for next year.
Float and Shares Shorts:
At present, 233.88 million ENDP shares are outstanding with a float of 233.27 million shares on hand for trading. On Apr 28, 2022, short shares totaled 35.11 million, which was 14.93% higher than short shares on Mar 30, 2022. In addition to Mr. Blaise A. Coleman as the firm’s Pres, CEO & Director, Mr. Mark T. Bradley serves as its Exec. VP & CFO.
Through their ownership of 84.57% of ENDP’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 56.15% of ENDP, in contrast to 26.69% held by mutual funds. Shares owned by individuals account for 2.29%. As the largest shareholder in ENDP with 14.65% of the stake, BlackRock Fund Advisors holds 34,445,128 shares worth 34,445,128. A second-largest stockholder of ENDP, The Vanguard Group, Inc., holds 27,836,643 shares, controlling over 11.84% of the firm’s shares. Paulson & Co., Inc. is the third largest shareholder in ENDP, holding 17,327,012 shares or 7.37% stake. With a 2.75% stake in ENDP, the Vanguard Total Stock Market Index is the largest stakeholder. A total of 6,458,450 shares are owned by the mutual fund manager. The iShares Russell 2000 ETF, which owns about 2.25% of ENDP stock, is the second-largest Mutual Fund holder. It holds 5,292,851 shares valued at 2.47 million. Vanguard Extended Market Index Fu holds 1.32% of the stake in ENDP, owning 3,091,975 shares worth 1.44 million.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ENDP since 5 analysts follow the stock currently. There are 0 analysts who recommend BUY ratings, while 3 suggest SELL ratings. Of the remaining analysts, 2 believe that the stock is worth HOLDING, 0 give it an OVERWEIGHT rating, and 0 thinks that it’s UNDERWEIGHT. In the same way, a target price assigned to a stock can also reveal much about its potential. With ENDP analysts setting a high price target of $2.00 and a low target of $1.00, the average target price over the next 12 months is $1.33. Based on these targets, ENDP could surge 344.44% to reach the target high and rise by 122.22% to reach the target low. Reaching the average price target will result in a growth of 195.56% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy. ENDP will report FY 2022 earnings on 02/28/2023. Analysts have provided yearly estimates in a range of $1.21 being high and $0.70 being low. For ENDP, this leads to a yearly average estimate of $0.91. The earnings surprise of a firm occurs when the actual results change from the consensus earnings estimate. Endo International plc surprised analysts by $0.22 when it reported $0.66 EPS against a consensus estimate of $0.44. The surprise factor in the prior quarter was $0.19. Based on analyst estimates, the high estimate for the next quarter is $0.44 and the low estimate is -$0.17. The average estimate for the next quarter is thus -$0.02.
Summary of Insider Activity:
Insiders traded ENDP stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 4 while that of sell transactions has risen to 18 over the past year. The total number of shares bought during that period was 98,016 while 354,685 shares were sold.